Valuation: Bio-Techne Corporation

Capitalization 9.48B 8.04B 7.37B 7B 12.94B 881B 13.21B 86.49B 34.01B 425B 35.55B 34.81B 1,503B P/E ratio 2026 *
48.2x
P/E ratio 2027 * 41.3x
Enterprise value 9.45B 8.02B 7.35B 6.98B 12.9B 879B 13.18B 86.25B 33.92B 424B 35.45B 34.72B 1,499B EV / Sales 2026 *
7.71x
EV / Sales 2027 * 6.99x
Free-Float
99.46%
Yield 2026 *
0.53%
Yield 2027 * 0.53%
1 day+2.28%
1 week+5.30%
Current month+15.92%
1 month+17.68%
3 months-12.92%
6 months-3.13%
Current year+3.01%
1 week 56.8
Extreme 56.795
60.89
1 month 50.56
Extreme 50.56
60.89
Current year 48.25
Extreme 48.25
72.16
1 year 46.05
Extreme 46.05
72.16
3 years 46.01
Extreme 46.01
89.91
5 years 46.01
Extreme 46.01
135.96
10 years 22.86
Extreme 22.8625
135.96
Manager TitleAgeSince
Chief Executive Officer 59 31/01/2024
Director of Finance/CFO 55 31/03/2014
Investor Relations Contact - 30/09/2019
Director TitleAgeSince
Chairman 70 01/11/2012
Director/Board Member 56 18/05/2009
Director/Board Member 63 25/10/2017
Change 5d. change 1-year change 3-years change Capi.($)
+2.28%+5.30%+25.95%-26.16% 9.27B
-3.20%+1.74%-2.45%-7.62% 48.69B
-1.79%+4.07%+37.70%+23.16% 35.92B
-1.61%+7.29%+297.80%+498.57% 31.26B
-0.96%+5.28%+35.78%+33.65% 29.77B
+0.17%+2.77%+22.83%-10.99% 29.62B
+0.37%-1.79%+52.27%+203.20% 15.1B
+1.51%+5.43%+78.36%+180.68% 14.87B
-0.43%+7.15%+40.29%+15.59% 14.5B
-1.99%-12.84%+3,566.97%+3,838.88% 14.18B
Average -0.57%+2.93%+415.55%+474.90% 24.32B
Weighted average by Cap. -1.15%+3.83%+269.89%+316.16%

Financials

2026 *2027 *
Net sales 1.23B 1.04B 953M 905M 1.67B 114B 1.71B 11.18B 4.4B 54.98B 4.6B 4.5B 194B 1.3B 1.1B 1.01B 961M 1.78B 121B 1.81B 11.87B 4.67B 58.39B 4.88B 4.78B 206B
Net income 197M 167M 153M 145M 269M 18.32B 275M 1.8B 707M 8.84B 739M 723M 31.23B 229M 194M 178M 169M 312M 21.28B 319M 2.09B 821M 10.26B 858M 840M 36.27B
Net Debt -25.76M -21.86M -20.04M -19.03M -35.16M -2.4B -35.91M -235M -92.45M -1.16B -96.62M -94.62M -4.08B -378M -321M -294M -280M -517M -35.2B -528M -3.45B -1.36B -16.98B -1.42B -1.39B -60.02B
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (71.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.4%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.3%). Net sales are distributed geographically as follows: the United States (56%), the United Kingdom (4.5%), Europe/Middle East/Africa (21.8%), China (8.3%), Asia/Pacific (6.3%) and other (3.1%).
Employees
3,100
Date Price Change Volume
20/04/26 60.58 $ +2.28% 2,011,864
17/04/26 59.23 $ +3.26% 1,925,348
16/04/26 57.36 $ -1.93% 2,034,916
15/04/26 58.49 $ -0.29% 1,500,662
14/04/26 58.66 $ +1.96% 2,543,741
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
60.58USD
Average target price
72.27USD
Spread / Average Target
+19.30%

Quarterly revenue - Rate of surprise